David Adler Research Interests Pharmaceutics Solubility - Phenytoin in IV Solutions Bioavailability/Clinical Equivalence - Sodium Warfarin - RCT Clinical.

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

The management of adverse drug reactions I Ralph Edwards
Chronic Medication Service (CMS). Programme Introduction Pharmaceutical Care Planning - Ray ePharmacy Programme – Dawn, IM & T Workshops – Niall, Michelle,
Prosthetic Valve; Anticoagulation After ICH Dr.Tahsin.N.
Selected Clinical Calculations
Newer Anticoagulants Drug Class Nicole N. Nguyen, PharmD Senior Clinical Pharmacist Health Care Services October 16, 2013.
Medications that impact bleeding By Nino Lalaiants Inesa Legrian NYCCT 2012.
Vascular Pharmacology
Bleeding time,clotting time, PT, and PTT
Medication Therapy Management Linda Mach, PharmD Bartell Drugs Community Practice Resident February 26, 2010.
Pharmacist Collaborative Practice Privileges in Diabetes Management
DR. HANA OMER CONGENITAL HEART DEFECTS. The major development of the fetal heart occurs between the fourth and seventh weeks of gestation, and most congenital.
Surgery with a Prosthetic Valve- What about the Warfarin? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Module 5 Postanalytical Phase of Laboratory Testing.
Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical.
Hemostasis and Blood Coagulation
ANTICOAGULANT BY :DR ISRAA OMAR.
WARFARIN AN OVERVIEW.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
Study Guide Guide for Patients Undergoing Anticoagulant Therapy.
Anticoagulation Transitions: Perioperative Care Alan Brush, MD, FACP Clinical Co-Director, Anticoagulation Management Service Harvard Vanguard Medical.
Mary Herbert, MS, MPH Clinical Director, Program for Health Care to Underserved Populations Sharon Connor, PharmD Assistant Professor, University of Pittsburgh,
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Anticoagulants By: Darrel Dejvongsa. About Anticoagulants Anticoagulants also called Blood Thinners help prevent existing blood clots form becoming larger.
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Jonathan H. Watanabe, PharmD, MS, PhD Research Interests Analysis of health services use and costs for patients without access to medications (applying.
Leadership for Advancing Chronic Care in Challenging Environments California Chronic Care Learning Communities Initiative Collaboration Kevin Grumbach,
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
Through its Quality efforts, the is… Supporting the appropriate use of new, transformational technologies and therapies Moving from a volume-to-value.
Drugs Used to Treat Thromboembolic Disorders Chapter 27 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
SSPPS Research Retreat January 8, 2015, Martin Johnson House, SIO Goals:  Develop new collaborative research among SSPPS faculty.  Develop translational.
Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix cancer center Impact of a “Transitions of Care” clinical.
Evidence-based medicine
CONGENITAL HEART DEFECTS DR. HANA OMER. CONGENITAL HEART DEFECTS D. HANA OMER.
Charles E. Daniels, BS Pharm., Ph.D. Research Interests Medication use and outcomes quality Medication distribution technology application Multihospital.
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
Shirley M. Tsunoda Liver Transplant, Drug Metabolism/PK Research Interests Investigating the genetic and environmental factors that influence variability.
Rabia Atayee Research Interests Opioid therapy Neuropathic pain and adjuvant therapy for pain Role of palliative care in the healthcare setting Teaching.
Agents Affecting Blood Clotting
Critical Care Department St. Michael’s Hospital Research Program © 2003 Critical Care Dept, St. Michael’s Hospital.
Åsa Gustafsson Research Interests Cardiovascular Disease Pathways that regulate life and death of cardiac myocytes Regulation of mitochondrial dynamics.
Low risk: young, with minor illnesses, who are to undergo operations lasting 30 min or less. Moderate risk: over 40 or with a debilitating illness who.
Joe Ma Research Interests: Drug Metabolism/PK and Pain Past: Examined and validated methods to evaluate drug-drug interaction/phenotyping studies (e.g.,
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Chronic Disease Tracking System  Problem  The current healthcare model focuses on one patient at a time in the office.  Chronic disease leads to higher.
미 국 에 서 의 병 원 약 사 의 역 할 서 옥 경, Pharm.D. 서울대학교 약학대학.
Non-vitamin K antagonist oral anticoagulants (NOACs)
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University.
Anticoagulant Therapy
Comparison of Patient Satisfaction and Time Spent in Therapeutic Range in Two Different Clinic Models Ashley Pokallus, PharmD PGY1 Pharmacy Resident—Ambulatory.
Warfarin Therapy Aaqid Akram MBChB (2013) Clinical Education Fellow.
Treatment of deep venous thrombosis and pulmonary embolism Anders Waage.
Date of download: 6/22/2016 From: An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism: A Randomized Trial Ann Intern Med. 2006;144(11):
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Practical Management of Anticoagulation in Patients.
Response to An Initial Dose of Warfarin in Thai Patients Undergoing Long-Term Anticoagulant Therapy Weerayuth Saelim R.Ph. 2 nd year Pharmacy resident.
Introduction - Perioperative management of patients on warfarin or antiplatelet therapy involves assessing and balancing individual risks for thromboembolism.
Aug, 2016.
Valvular heart disease
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
Selecting NOACs for High-Risk Patients
Current Concepts in Anticoagulant Therapy
Hematology and Coagulation Procedures
GHS Outpatient Enoxaparin Program
Time in therapeutic range in patients with atrial fibrillation treated with warfarin at Tullinge primary care centre. Time in therapeutic range in patients.
by Deborah M. Stephens, and John C. Byrd
What Do the Guidelines Say About The Role of the HF Nurse?
Presentation transcript:

David Adler Research Interests Pharmaceutics Solubility - Phenytoin in IV Solutions Bioavailability/Clinical Equivalence - Sodium Warfarin - RCT Clinical Toxicology - Removal of Drugs by Hemodialysis Instrumentation Point – of – Care - Capillary Whole Blood Prothrombin Time/INR - Warfarin Capillary Whole Blood Activated Partial Thromboplastin Time - Heparin Drug Therapy Management in Chronic Disease – Outcomes of Collaborative Medication Management – RCT Curricular Impact on Student Quality of Life – Survey Access to Care in Underserved Communities – Hepatitis B

Core Expertise Clinical Therapeutics -Anticoagulation -Others Clinical Practice Base - Management of Chronic Disease Clinical Population Applications of Point-of-Care Testing

Proposed Collaborations with SSPPS Faculty Medication Therapy Management Specialty Care Drug Therapy Management Primary Care Drug Therapy Management Translational Opportunities in Patients with Venous Thromboembolic Disease Select patient populations with: Atrial Fibrillation Deep Venous Thrombosis Mechanical Heart Valves Drug Interactions - Unanswered Questions: Natural Products – e.g. Mango influence on elevating PT/INR Drug-Drug Interactions – MOA and Management of Therapy